IL236618A - Process and intermediates for preparation of integration inhibitors - Google Patents

Process and intermediates for preparation of integration inhibitors

Info

Publication number
IL236618A
IL236618A IL236618A IL23661815A IL236618A IL 236618 A IL236618 A IL 236618A IL 236618 A IL236618 A IL 236618A IL 23661815 A IL23661815 A IL 23661815A IL 236618 A IL236618 A IL 236618A
Authority
IL
Israel
Prior art keywords
intermediates
integrase inhibitors
preparing integrase
preparing
inhibitors
Prior art date
Application number
IL236618A
Other languages
English (en)
Hebrew (he)
Other versions
IL236618A0 (en
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of IL236618A0 publication Critical patent/IL236618A0/en
Publication of IL236618A publication Critical patent/IL236618A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/12—Preparation of carboxylic acid esters from asymmetrical anhydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
IL236618A 2012-08-03 2015-01-11 Process and intermediates for preparation of integration inhibitors IL236618A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261679475P 2012-08-03 2012-08-03
PCT/US2013/053295 WO2014022707A1 (en) 2012-08-03 2013-08-01 Process and intermediates for preparing integrase inhibitors

Publications (2)

Publication Number Publication Date
IL236618A0 IL236618A0 (en) 2015-02-26
IL236618A true IL236618A (en) 2017-04-30

Family

ID=48980354

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236618A IL236618A (en) 2012-08-03 2015-01-11 Process and intermediates for preparation of integration inhibitors

Country Status (17)

Country Link
US (1) US8877931B2 (enExample)
EP (1) EP2880017B1 (enExample)
JP (1) JP6147856B2 (enExample)
KR (1) KR20150040340A (enExample)
CN (1) CN104520275B (enExample)
AU (1) AU2013296289B2 (enExample)
BR (1) BR112015002275A2 (enExample)
CA (1) CA2878699C (enExample)
EA (1) EA026089B1 (enExample)
ES (1) ES2608860T3 (enExample)
IL (1) IL236618A (enExample)
IN (1) IN2015DN01688A (enExample)
MX (1) MX337094B (enExample)
NZ (1) NZ630199A (enExample)
PT (1) PT2880017T (enExample)
SG (1) SG11201500812QA (enExample)
WO (1) WO2014022707A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030003B1 (ru) 2012-12-21 2018-06-29 Джилид Сайэнс, Инк. Полициклическое карбамоилпиридоновое соединение и его фармацевтическое применение для лечения вич-инфекции
NO2865735T3 (enExample) 2013-07-12 2018-07-21
DK3019503T3 (da) 2013-07-12 2017-11-20 Gilead Sciences Inc Polycykliske-carbamoylpyridon-forbindelser og anvendelse deraf til behandling af hiv-infektioner
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
NO2717902T3 (enExample) 2014-06-20 2018-06-23
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
CA2980362C (en) 2015-04-02 2020-02-25 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
EP4036096A4 (en) * 2019-09-24 2023-08-09 Asymchem Laboratories (Tianjin) Co., Ltd. METHOD FOR THE CONTINUOUS PREPARATION OF ZINC BENZYL HALIDE AND ITS DERIVATIVES
CN112661698A (zh) * 2021-01-14 2021-04-16 浙江海森药业股份有限公司 一种艾维雷韦的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904108D0 (sv) * 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
HUP0303991A3 (en) 2000-12-14 2012-09-28 Warner Chilcott Company Cyclization process step in the making of quinolones and naphthyridines
TW200300349A (en) 2001-11-19 2003-06-01 Sankyo Co A 4-oxoqinoline derivative
US20050104233A1 (en) 2002-05-31 2005-05-19 Shinji Kato Method of substituent introduction through halogen-metal exchange reaction
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
TW200409759A (en) 2002-09-25 2004-06-16 Wyeth Corp Substituted 4-(indazol-3-yl)phenols
US7176220B2 (en) 2002-11-20 2007-02-13 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as pharmaceutical agent
EP1582523A1 (en) 2004-04-02 2005-10-05 Ludwig-Maximilians-Universität München Method of preparing organomagnesium compounds
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
MY134672A (en) 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
US7531554B2 (en) 2004-05-20 2009-05-12 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
US8633219B2 (en) 2004-05-21 2014-01-21 Japan Tobacco Inc. Combination therapy
WO2007063869A1 (ja) 2005-11-30 2007-06-07 Japan Tobacco Inc. 高純度キノロン化合物の製造方法
US20090233964A1 (en) 2005-12-30 2009-09-17 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
CN101437801B (zh) 2006-03-06 2013-02-06 日本烟草产业株式会社 制备4-氧代喹啉化合物的方法
JP4669040B2 (ja) 2006-03-06 2011-04-13 日本たばこ産業株式会社 4−オキソキノリン化合物の製造方法
TW200811153A (en) 2006-06-23 2008-03-01 Japan Tobacco Inc 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
ES2536923T3 (es) 2006-09-12 2015-05-29 Gilead Sciences, Inc. Proceso e intermedios para preparar inhibidores de la integrasa del VIH
SG182229A1 (en) 2007-06-29 2012-07-30 Gilead Sciences Inc Therapeutic compositions and the use thereof
WO2009006203A1 (en) 2007-06-29 2009-01-08 Gilead Sciences, Inc. Therapeutic compositions and the use thereof
AR068403A1 (es) * 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa

Also Published As

Publication number Publication date
SG11201500812QA (en) 2015-04-29
CN104520275B (zh) 2016-11-02
EA026089B1 (ru) 2017-02-28
EP2880017B1 (en) 2016-10-05
JP6147856B2 (ja) 2017-06-14
KR20150040340A (ko) 2015-04-14
NZ630199A (en) 2016-12-23
HK1209415A1 (en) 2016-04-01
WO2014022707A1 (en) 2014-02-06
MX2015001506A (es) 2015-04-08
CA2878699C (en) 2018-09-11
EP2880017A1 (en) 2015-06-10
US8877931B2 (en) 2014-11-04
ES2608860T3 (es) 2017-04-17
CA2878699A1 (en) 2014-02-06
EA201590018A1 (ru) 2015-05-29
IL236618A0 (en) 2015-02-26
IN2015DN01688A (enExample) 2015-07-03
BR112015002275A2 (pt) 2017-07-04
CN104520275A (zh) 2015-04-15
AU2013296289B2 (en) 2017-10-05
JP2015524822A (ja) 2015-08-27
AU2013296289A1 (en) 2015-02-19
PT2880017T (pt) 2016-12-14
HK1209748A1 (en) 2016-04-08
MX337094B (es) 2016-02-10
US20140039194A1 (en) 2014-02-06

Similar Documents

Publication Publication Date Title
IL238314A (en) Process for the preparation of an important compound of linagliptin
IL235826A (en) Diazaspirocycloalkanes and thenaspirocycloalkanes and their preparation
PL2549870T3 (pl) Sposób wytwarzania pochodnych karbamoilopirydonu i związków pośrednich
IL232139A0 (en) A process for the preparation of quinoline hist
IL236618A0 (en) Process and intermediates for the preparation of integrase inhibitors
IL237655A0 (en) An improved process for the preparation of vilantrol and intermediates
EP2536724A4 (en) PROCESS FOR PREPARING THE ENTÉCAVIR AND ITS INTERMEDIATES
SG11201406623PA (en) Process for the preparation of rivaroxaban and intermediates thereof
IL233654A0 (en) Methods and intermediates for the preparation of pharmaceutical agents
EP2807261A4 (en) PROCESS FOR CULTIVATION OF MONARDA FISTULOSA
IL235420A (en) Process for making rebroxban by using intermediates
AP2014007906A0 (en) Chemical process for preparing spiroindolones and intermediates thereof
IL235805A (en) Pyrimidinyl-Diazaspiro compound and process for preparation
GB201214452D0 (en) Apparatus for the culture of parasites
IL239228A0 (en) Improved process for the preparation of n-cyano-s-[1-(pyridine-3-yl)ethyl]-s-methylsulfylamines
IL233388A (en) Process for the preparation of acetanilides
GB201320366D0 (en) Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein
IL234366A (en) Process for preparation of roflumilast
ZA201408568B (en) Intermediates and processes for preparing compounds
HUP1300722A2 (en) Norsteroid intermediates and process for their preparation
GB201311165D0 (en) Diastereoselective process for preparing statin intermediates
GB201215646D0 (en) Process

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees